Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”-Reference-Cited by-同舟云学术

Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism”

Published:2019-09-28 Issue:2 Volume:179 Page:519-520
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vitiello Glauco Akelinghton Freire,Amarante Marla Karine,Banin-Hirata Bruna Karina,Campos Clodoaldo Zago,de Oliveira Karen Brajão,Losi-Guembarovski Roberta,Watanabe Maria Angelica Ehara

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05452-0.pdf

Reference13 articles.

1. Vitiello GAF, Amarante MK, Banin-Hirata BK, Campos CZ, de Oliveira KB, Losi-Guembarovski R, Watanabe MAE (2019) Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-019-05370-1

2. Yasri S, Wiwanitkit V (2019) Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-019-05414-6

3. Seijo ER, Song H, Lynch MA, Jennings R, Qong X, Lazaridis E, Muro-Cacho C, Weghorst CM, Muñoz-Antonia T (2001) Identification of genetic alterations in the TGFβ type II receptor gene promoter. Mutat Res/Fundam Mol Mech Mutagen 483(1–2):19–26. https://doi.org/10.1016/s0027-5107(01)00217-2

4. Choe B-K, Kim SK, Park HJ, Park H-K, Kwon KH, Lim SH, Yim S-V (2012) Polymorphisms of TGFBR2 contribute to the progression of papillary thyroid carcinoma. Mol Cell Toxicol 8(1):1–8. https://doi.org/10.1007/s13273-012-0001-0

5. Huang Y-S, Zhong Y, Yu L, Wang L (2014) Association between the TGFBR2 G-875A polymorphism and cancer risk: evidence from a meta-analysis. Asian Pac J Cancer Prev 15(20):8705–8708. https://doi.org/10.7314/apjcp.2014.15.20.8705